Login to Your Account


Panelists: Positives amid setbacks in cell therapy, regenerative medicine space

By Nuala Moran
Staff Writer

Wednesday, May 21, 2014
LONDON – There are storm clouds on the horizon for cell therapy and regenerative medicine, with a number of trial failures in the past few weeks and the mounting problems in getting reimbursement for high-cost products that are edging to market, adding to the huge scientific and development challenges that the sector faces.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription